A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

India's top drugmaker by revenue Sun Pharma on Monday launched its anti-baldness drug Leqselvi in the U.S., following the ...

Children of various racial and ethnic minority groups have a higher prevalence of alopecia areata than non-Hispanic White children.

Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about ...

"With these data, baricitinib is the most well-studied JAK inhibitor in severe alopecia areata, a chronic immune system disorder that can have an especially devastating social and emotional impact ...